Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coronin, actin binding protein 1B (CORO1B) is an intracellular, WD repeat-containing actin-binding protein that regulates actin cytoskeleton remodeling. It localizes to the leading edge of migrating cells, coordinating the disassembly and remodeling of Arp2/3-mediated branched actin networks in lamellipodia by interacting with cortactin and cofilin. In endothelial and epithelial cells, CORO1B plays a critical role in cell–cell junction stability and tube formation during angiogenesis. Phosphorylation by kinases such as PKC modulates its activities. While it is widely expressed and essential for fundamental cellular processes, it is not currently considered a direct druggable target, though it is implicated in cell migration, vessel formation, and possibly cancer and neural repair[1][2][3][4][5].
Not applicable; no drugs with known mechanism of action targeting CORO1B directly. CORO1B functions by antagonizing cortactin, promoting actin branch debranching, and modulating interactions with Arp2/3 and cofilin[2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coronin, actin binding protein 1B (CORO1B).